230 related articles for article (PubMed ID: 12097256)
1. Prospective molecular profiling of melanoma metastases suggests classifiers of immune responsiveness.
Wang E; Miller LD; Ohnmacht GA; Mocellin S; Perez-Diez A; Petersen D; Zhao Y; Simon R; Powell JI; Asaki E; Alexander HR; Duray PH; Herlyn M; Restifo NP; Liu ET; Rosenberg SA; Marincola FM
Cancer Res; 2002 Jul; 62(13):3581-6. PubMed ID: 12097256
[TBL] [Abstract][Full Text] [Related]
2. Differential gene expression profiling of primary cutaneous melanoma and sentinel lymph node metastases.
Koh SS; Wei JP; Li X; Huang RR; Doan NB; Scolyer RA; Cochran AJ; Binder SW
Mod Pathol; 2012 Jun; 25(6):828-37. PubMed ID: 22411186
[TBL] [Abstract][Full Text] [Related]
3. cDNA arrays and the enigma of melanoma immune responsiveness.
Wang E; Marincola FM
Cancer J; 2001; 7(1):16-24. PubMed ID: 11269643
[TBL] [Abstract][Full Text] [Related]
4. Metastatic lesions with and without interleukin-18-dependent genes in advanced-stage melanoma patients.
Crende O; Sabatino M; Valcárcel M; Carrascal T; Riestra P; López-Guerrero JA; Nagore E; Mandruzzato S; Wang E; Marincola FM; Vidal-Vanaclocha F
Am J Pathol; 2013 Jul; 183(1):69-82. PubMed ID: 23707237
[TBL] [Abstract][Full Text] [Related]
5. A natural history of melanoma: serial gene expression analysis.
Wang E; Marincola FM
Immunol Today; 2000 Dec; 21(12):619-23. PubMed ID: 11114422
[TBL] [Abstract][Full Text] [Related]
6. Identification of candidate tumor oncogenes by integrative molecular analysis of choroidal melanoma fine-needle aspiration biopsy specimens.
McCannel TA; Burgess BL; Rao NP; Nelson SF; Straatsma BR
Arch Ophthalmol; 2010 Sep; 128(9):1170-7. PubMed ID: 20837802
[TBL] [Abstract][Full Text] [Related]
7. Molecular insights on the peripheral and intratumoral effects of systemic high-dose rIL-2 (aldesleukin) administration for the treatment of metastatic melanoma.
Weiss GR; Grosh WW; Chianese-Bullock KA; Zhao Y; Liu H; Slingluff CL; Marincola FM; Wang E
Clin Cancer Res; 2011 Dec; 17(23):7440-50. PubMed ID: 21976537
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of immune response during immunotherapy.
Panelli MC; Nagorsen D; Wang E; Monsurro V; Jin P; Katia Z; Smith K; Ngalame Y; Marincola FM
Yonsei Med J; 2004 Jun; 45 Suppl():15-7. PubMed ID: 15250044
[TBL] [Abstract][Full Text] [Related]
9. Expansion of tumor-T cell pairs from fine needle aspirates of melanoma metastases.
Panelli MC; Riker A; Kammula U; Wang E; Lee KH; Rosenberg SA; Marincola FM
J Immunol; 2000 Jan; 164(1):495-504. PubMed ID: 10605047
[TBL] [Abstract][Full Text] [Related]
10. Molecular and epigenetic features of melanomas and tumor immune microenvironment linked to durable remission to ipilimumab-based immunotherapy in metastatic patients.
Seremet T; Koch A; Jansen Y; Schreuer M; Wilgenhof S; Del Marmol V; Liènard D; Thielemans K; Schats K; Kockx M; Van Criekinge W; Coulie PG; De Meyer T; van Baren N; Neyns B
J Transl Med; 2016 Aug; 14(1):232. PubMed ID: 27484791
[TBL] [Abstract][Full Text] [Related]
11. Predictive gene signature in MAGE-A3 antigen-specific cancer immunotherapy.
Ulloa-Montoya F; Louahed J; Dizier B; Gruselle O; Spiessens B; Lehmann FF; Suciu S; Kruit WH; Eggermont AM; Vansteenkiste J; Brichard VG
J Clin Oncol; 2013 Jul; 31(19):2388-95. PubMed ID: 23715562
[TBL] [Abstract][Full Text] [Related]
12. Integrated differential DNA methylation and gene expression of formalin-fixed paraffin-embedded uveal melanoma specimens identifies genes associated with early metastasis and poor prognosis.
Ness C; Katta K; Garred Ø; Kumar T; Olstad OK; Petrovski G; Moe MC; Noer A
Exp Eye Res; 2021 Feb; 203():108426. PubMed ID: 33387485
[TBL] [Abstract][Full Text] [Related]
13. Biochemotherapy of metastatic malignant melanoma. Predictive value of tumour-infiltrating lymphocytes.
Håkansson A; Gustafsson B; Krysander L; Hjelmqvist B; Rettrup B; Håkansson L
Br J Cancer; 2001 Dec; 85(12):1871-7. PubMed ID: 11747328
[TBL] [Abstract][Full Text] [Related]
14. Kinetics of cytokine expression in melanoma metastases classifies immune responsiveness.
Mocellin S; Ohnmacht GA; Wang E; Marincola FM
Int J Cancer; 2001 Jul; 93(2):236-42. PubMed ID: 11410872
[TBL] [Abstract][Full Text] [Related]
15. Tumor CD155 Expression Is Associated with Resistance to Anti-PD1 Immunotherapy in Metastatic Melanoma.
Lepletier A; Madore J; O'Donnell JS; Johnston RL; Li XY; McDonald E; Ahern E; Kuchel A; Eastgate M; Pearson SA; Mallardo D; Ascierto PA; Massi D; Merelli B; Mandala M; Wilmott JS; Menzies AM; Leduc C; Stagg J; Routy B; Long GV; Scolyer RA; Bald T; Waddell N; Dougall WC; Teng MWL; Smyth MJ
Clin Cancer Res; 2020 Jul; 26(14):3671-3681. PubMed ID: 32345648
[TBL] [Abstract][Full Text] [Related]
16. CD40 expression by human melanocytic lesions and melanoma cell lines and direct CD40 targeting with the therapeutic anti-CD40 antibody CP-870,893.
Kalbasi A; Fonsatti E; Natali PG; Altomonte M; Bertocci E; Cutaia O; Calabrò L; Chiou M; Tap W; Chmielowski B; Maio M; Ribas A
J Immunother; 2010 Oct; 33(8):810-6. PubMed ID: 20842056
[TBL] [Abstract][Full Text] [Related]
17. Additive Role of Immune System Infiltration and Angiogenesis in Uveal Melanoma Progression.
García-Mulero S; Alonso MH; Del Carpio LP; Sanz-Pamplona R; Piulats JM
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800878
[TBL] [Abstract][Full Text] [Related]
18. Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survival.
Bogunovic D; O'Neill DW; Belitskaya-Levy I; Vacic V; Yu YL; Adams S; Darvishian F; Berman R; Shapiro R; Pavlick AC; Lonardi S; Zavadil J; Osman I; Bhardwaj N
Proc Natl Acad Sci U S A; 2009 Dec; 106(48):20429-34. PubMed ID: 19915147
[TBL] [Abstract][Full Text] [Related]
19. Melanoma antigen expression in serial fine-needle aspiration samples in patients with metastatic malignant melanoma participating in immunotherapy clinical trials: a preliminary look.
Fetsch PA; Steinberg SM; Riker AI; Marincola FM; Abati A
Cancer; 2001 Dec; 93(6):409-14. PubMed ID: 11748581
[TBL] [Abstract][Full Text] [Related]
20. Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi.
Sand M; Skrygan M; Sand D; Georgas D; Gambichler T; Hahn SA; Altmeyer P; Bechara FG
Cell Tissue Res; 2013 Jan; 351(1):85-98. PubMed ID: 23111773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
